XU FUJIE附属第一医院 | 医学院公共卫生与预防医学流行病学个人简介:毕业于北京医科大学，从美国Emory大学获得流行病学博士学位并完成了Epidemic Intelligence Services 博士后培训。 曾任职于美国联邦疾病控制中心（CDC）和美国吉利得药物科技公司。从事流行病学研究近20年，主要研究病方向为病毒性肝炎，新发传染病、HIV、性病和疫苗。曾主持多中心流行病学长期队列研究、随机对照临床试验、评价公共卫生疾病预防和治疗措施的安全性和真实世界效、 传染病模型、实验室检测方法评价和成本效益评价等。 2016年入选国家“千人计划”，2017年3月起全职在浙江大学工作。教学与课程:临床医学研究设计科研:从事感染性疾病流行病学工作20年，研究HIV预防、性病诊断、流感疫苗评价、病毒性肝炎治疗等。 曾担任美国疾病控制中心病毒性肝炎流行病学和科研负责人和 Gilead 药物科学公司医学事务和公共卫生总监。她的多项成果发表在国际知名学术期刊上，包括最有影响力的新英格兰医学(NEJM)和美国医学会杂志(JAMA)。2017年起任职于浙江大学医学院附属第一医院，主要从事感染性疾病的治疗与预防研究和基于临床的试验研究和队列研究。研究与成果:1.        Xu F Guo Y. Communicable diseases and the gene revolution. Lancet Global Health (In Press).2.        Cui F Woodring J Chan P Xu F. Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China. International Journal of Epidemiology https://doi.org/10.1093/ije/dyy0773.        Teshale EH Xing J Moorman A Holmberg SD Spradling PR Gordon SC Rupp LB Lu M Boscarino JA Trinacity CM Schmidt MA Xu F; CHeCS Investigators. Higher all-cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CHeCS) 2006-2013. J Viral Hepat. 2016; 3(10):748-54. doi: 10.1111/jvh.12548.4.        Xu F Moorman AC Tong et al. All-cause mortality and progression risks to hepatic decompensation and hepatocellular carcinoma in patients infected with hepatitis C by biopsy-determined fibrosis stage. Clinical Infectious Disease 2016; 62(3):289-297. doi: 10.1093/cid/civ860.5.        Xu F Leidner AJ Tong X Holmberg SD. Estimating the number of patients infected with chronic hepatitis C virus meeting ‘highest’ or ‘high’ priority treatment criteria in the United States.  American Journal of Public Health 2015. Vol. 105(7): 1285-1289.http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2015.302652.6.        Allison RD. Tong X Moorman AC Ly KN Rupp L Xu F Holmberg SD. Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection 2006-2010. Journal of Hepatology 2015. Epub: http://authors.elsevier.com/sd/article/S0168827815003049.7.        Moorman AC Stramer SL Schaefer MK Collier MG Suryaprasad A Kuehnert MJ Moore Z Rowan E Habicht K Bradley K Mei-chen F Kopkins C Xu F. Incident hepatitis among repeat blood donors; a sentinel event signaling possible healthcare associated infection and need for reporting to public health authorities. Transfusion 2015. Epub: http://onlinelibrary.wiley.com/doi/10.1111/trf.13132/abstract8.        Gordon SC et al. Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): A Retrospective and prospective observational study. American Journal of Gastroenterology 2015. Epub: www.amedeo.com/p2.php?id=26215529&s=hep&pm=29.        Leidner AJ Chesson HW Xu F Ward JW Spradling PR Holmberg SD. Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease. Hepatology 2015. Vol 61(6): 1860–1869. http://onlinelibrary.wiley.com/doi/10.1002/hep.27736/abstract.10.    Leidner AJ Chesson HW Xu F Spradling PR Holmberg SD. The effect of including potential reductions in non-hepatic mortality on the estimated cost-effectiveness of hepatitis C treatment in early stages of liver disease. Medical Decision Making (under revision).11.    Collier MG Tong X Xu F. Hepatitis A hospitalizations in the United States 2002 – 2011. Hepatology 2015. Vol 61(2):481-485.12.    Gerbi G Williams R Barnabas B Liu S Downing R Drobeniuc J Saleem K Xu F Holmberg SH Teshale E. Hepatitis E as a cause of acute jaundice syndrome in northern Uganda 2010-2012. American Journal of Tropical Medicine & Hygiene 2015. Vol 92(2):411-4.13.    Moorman AC Xing J Ko S Rupp LB Xu F et al. Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): missed opportunities for intervention. Hepatology 2015. Vol 61(5): 1479–1484.14.    Xu F Tong X Leidner AJ. Hospitalizations and costs associated with hepatitis C virus and advanced liver disease continue to increase. Health Affairs 2014. Vol 33:1728-1735.15.    Collier M Khudyakov Y Selvage D Adams-Cameron M Epson E Cronquist A Jervis RLamba K Kimura A Sowadsky R Hassan R Park S Garza E Rotstein D Beal J Kuntz TLance S Dreisch R Wise M Nelson N Suryaprasad A Drobeniuc J Holmberg S Xu F.Outbreak of Hepatitis A in the USA associated with frozen pomegranate arils imported from Turkey: an epidemiological and genetic case study. Lancet Infect Dis. 2014. Vol 14(10):976-981.16.    Zhang L Ko S Lv J Ji F Yan B Xu F et al. Perinatal Hepatitis B Prevention Program in Shandong Province China: Evaluation and Progress. Human Vaccination & Immunotherapeutics 2014. Vol 10(9):2755-2760.17.    Suryaprasad AG White JZ Xu F et al. Emerging epidemic of hepatitis C virus infections among young non-urban persons who inject drugs in the United States 2006–2012. Clinical Infectious Disease 2014. Vol 59(10):1411-1419.18.    Gerbi GB Rupp LB Ko SC Moorman AC Holmberg SD Xu F; CHeCS Investigators. Reported reasons for testing among hepatitis B virus-infected patients - Chronic Hepatitis Cohort Study (CHeCS) United States 2006-2010. Liver Int. 2014; 34(6):e162-3.19.    Liu G Holmberg SD Kamil S Xu F. Racial disparities in the proportion of current Hepatitis C virus infections in the United States 2003-2010. Dig Dis and Sci. 2014. Vol 59:1950–1957.20.    Oster AM Sternberg M Nebenzahl S Broz D Xu F Hariri S Miles I Paz-Bailey G. Prevalence of HIV STIs and viral hepatitis by urbanicity among MSM IDUs and heterosexuals in the United States. Sexually Transmitted Diseases 2014. Vol 41:272–279.21.    Mahajan R et al. Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS) 2006-2010. Clinical Infectious Diseases 2014. Vol 58:1055-61.22.    Fanfair R Zaidi A Taylor LD Xu F Gottlieb SL Markowitz LE. Trends in seroprevalence of herpes simplex virus type 2 among Non-Hispanic Blacks and Non-Hispanic Whites Aged 14-49 Years—United States 1988-2010. Sexually Transmitted Diseases 2013. Vol 40: 860-864.23.    Darville D and the pelvic inflammatory disease workshop proceedings committee. Pelvic inflammatory disease: identifying research gaps—Proceedings of a workshop sponsored by Department of Health and Human Services/National Institutes of Health/National Institute of Allergy and Infectious Diseases November 3–4 2011. Sexually Transmitted Diseases 2013. Vol. 40: 761-767.24.    Ko CS et al. Locations and Reasons for Initial Testing for Hepatitis C Infection — Chronic Hepatitis Cohort Study United States 2006–2010. Morbidity and Mortality Weekly Report 2013. 62:645-648.25.    Introcaso CE Xu F Kilmarx PH Markowitz LE. Prevalence of circumcision among men and boys aged 14–59 years in the United States National Health and Nutrition Examination Surveys 2005–2010. Sexually Transmitted Diseases 2013. Vol. 40:521-525.26.    Kirkey K et al. Completeness of Reporting of Chronic Hepatitis B and C Virus Infections — Michigan 1995–2008. Morbidity and Mortality Weekly Report 2013. Vol. 62; 99-102.27.    Satterwhite CL et al. Sexually transmitted infections among US women and men: Prevalence and incidence estimates 2008. Sexually Transmitted Diseases 2013. Vol. 40:187-193.28.    Gottlieb SL Xu F Brunham RC. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: Interpretation of findings from randomized controlled trials. Sexually Transmitted Diseases 2013. Vol. 40:97-102.29.    Gorwitz1 R Sereday K Van der Pol B Kwok C Morrison C Papp J Xu F Markowitz L. Development and persistence of anti-Chlamydial antibodies in women with incident Chlamydia Trachomatis Infections in Uganda and Zimbabwe. Sex Transmitted Infection 2013. Vol 89: A74 doi:10.1136/sextrans-2013-051184.0223.30.    Xu F Stoner BP Taylor SN Mena L Martin DH Powell S Markowitz LE. “Testing-only” visits: An assessment of missed diagnoses in clients attending sexually transmitted disease clinics. Sexually Transmitted Diseases 2013. Vol. 40:64-69.31.    McIntosh YG et al. Multiple outbreaks of hepatitis B virus infection related to assisted monitoring of blood glucose among residents of assisted living facilities-Virginia 2009-2011. Morbidity and Mortality Weekly Report 2012. Vol. 61 No.19: 339-343.32.    Pratt L Xu F McQuillan G Robitz R. The association of depression risky sexual behaviours and herpes simplex virus type 2 in adults in NHANES 2005-2008. Sexually Transmitted Diseases 2012. 88:40-44.33.    Xu F Stoner BP Taylor SN et al. Use of Home-based vaginal swabs to facilitate rescreening for Chlamydia trachomatis infections: Two randomized controlled Trials. Obstetrics & Gynecology 2011. 118:231-239.34.    Howard EJ Xu F Taylor SN Stoner BP Mena L Nsuami MJ Powell S Lillis R Martin DM. Screening methods for Chlamydia trachomatis and Neisseria gonorrhoeae infections in STD Clinics: What do patients prefer? Sexually Transmitted Infections 2011. 87:149-51.35.    Howard EJ Xu F Taylor SN Stoner BP Mena L Nsuami MJ Powell S Lillis R Martin DH. Patient preference for patient-delivered partner therapy: Exploratory findings from three STD Clinics. Sexually Transmitted Diseases 2011. 38:148-149.36.    Wu J Xu F Lu L Lu M Miao L Gao T Ji W Suo L Liu D Ma R Yu R Zhangzhu J Liu W Zeng Y Li X Zhang X Pang X Deng Y. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. New England Journal of Medicine 2010. 363:2416-2423.37.    Xu F Sternberg M Marlowitz LE. Men who have sex men in the United States: Demographic and behavioral characteristics and prevalence of HIV and HSV-2 infection—Results from National Health and Nutrition Examination Survey 2001-2006. Sexually Transmitted Diseases 2010. 37:399-405.38.    Xu F Sternberg M Marlowitz LE. Women who have sex with women in the United States: Prevalence sexual behavior and prevalence of herpes simplex virus type 2 infection—Results from National Health and Nutrition Examination Survey 2001-2006. Sexually Transmitted Diseases 2010. 37: 407-413.39.    Batteiger BE Xu F Johnson RE Rekart ML. Protective Immunity to Chlamydia trachomatis genital infection: Evidence from human studies. The Journal of Infectious Diseases 2010. 201 (S2): S178-189.40.    Gottlieb SL Martin DH Xu F Byrne GI Brunham RC. Summary: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control. The Journal of Infectious Diseases 2010. 201 (S2): S190-204.41.    Xu F Sternberg M Gottlieb SL Berman SM Markowitz LE Forhan SE Taylor LD. Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years—United States 2005-2008. Morbidity and Mortality Weekly Report 2010. Vol. 59 No.15: 456-459.42.    Xu F Gee JM  Naleway A et al. Incidence of Neonatal Herpes Simplex Virus Infections in Two Managed Care Organizations: Implications for Surveillance. Sexually Transmitted Diseases 2008. Vol 35: 592-59843.    Xu F Markowitz LE Sternberg M Aral A. Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States. Sexually Transmitted Diseases 2007. Vol 34: 479-484.44.    Xu F Lee FK Morrow RA et al. Seroprevalence of herpes simplex virus type 1 in children in the United States. Journal of Pediatrics 2007. Vol 151: 336-338.45.    Xu F Markowitz LE Gottlieb SL Berman SM. Seroprevalence of herpes simplex virus type 1 and type 2 in pregnant women in the United States. The American Journal of Obstetrics & Gynecology 2007; Vol 196: 43.e1-e6.46.    Xu F Sternberg M Kottiri B McQuillan G Lee F Nahmias A Berman S Markowitz LE. National trends in herpes simplex virus type 1 and type 2 in the United States: Data from the National Health and Nutrition Examination Survey (NHANES). JAMA 2006; Vol 296: 964-973.47.    Wu J Xu F Zhou W et al. SARS among persons without known contact with SARS patients Beijing China. Emerging Infectious Diseases 2004; Vol 10: 210-216.48.    Schillinger J Xu F Armstrong GL et al. National seroprevalence and trends in herpes simplex virus type 1 in the United States 1976-1994. Sexually Transmitted Diseases 2004; Vol 31:753-760.49.    Pang X Zhu Z Xu F et al. Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing 2003. JAMA 2003. Vol 290: 3215-3221.50.    Xu F Schillinger J Sternberg M et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States 1988-1994. The Journal of Infectious Diseases 2002. Vol 185: 1019-1024.